Inhibitors of 3C cysteine proteinases from Picornaviridae

Current Topics in Medicinal Chemistry

Volumn 4, Issue 12, 2004, Pages 1239-1253

  Lall, Manjinder S ^a   Jain, Rajendra P ^a   Vederas, John C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; AMIDE; AMINE; AZETIDINONE DERIVATIVE; AZO COMPOUND; BROMOACETYL AZAPEPTIDE DERIVATIVE; CARBONYL DERIVATIVE; CATHEPSIN K; CHYMOTRYPSIN; CYSTEINE PROTEINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUNCTIONAL GROUP; HETEROCYCLIC KETONE; HYDRAZIDE DERIVATIVE; HYDRAZINE; IODOACETAMIDE; KETONE; LACTONE DERIVATIVE; MACROCYCLIC COMPOUND; OXAZOLONE; PEPTIDE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; PROTEIN PRECURSOR; PSEUDOOXAZOLONE; RHODIUM; RNA; THIOL; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ENZYME;

DRUG DESIGN; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME LOCALIZATION; HEPATITIS A VIRUS; HUMAN RHINOVIRUS; IC 50; INHIBITION KINETICS; MASS SPECTROMETER; MICHAEL ADDITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PICORNAVIRUS; PROTEIN SYNTHESIS; REVIEW; VIROGENESIS; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PICORNAVIRIDAE; PICORNAVIRIDAE INFECTIONS; PROTEIN FOLDING;

EID: 4444229711     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043387836     Document Type: Review

References (93)

1. Ikuta, K.; Suzuki, S.; Horikoshi, H.; Mukai, T.; Luftig, R. B. Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis. Microbiol. Mol. Biol. Rev. 2000, 64, 725-745.
2. Roose, J. P.; Van Noorden, C. J. F. Synthetic Protease Inhibitors: Promising Compounds to Arrest Pathological Processes. J. Lab. Clin. Med. 1995, 125, 433-441.
3. Otto, H.-H.; Schirmeister, T. Cysteine Proteases and Their Inhibitors. Chem. Rev. 1997, 97, 133-171.
4. Symposium-in-Print: Bioorg. Med. Chem. 1999, 7, 571-644.
5. Leung, D.; Abbenante, G.; Fairlie, D. P. Protease Inhibitors: Current Status and Future Prospects. J. Med. Chem. 2000, 43, 305-341.
6. Leung-Toung, R.; Li, W.; Tam, T. F.; Kaarimian, K. Thiol-Dependent Enzymes and Their Inhibitors: A Review. Curr. Med. Chem. 2002, 9, 979-1002.
7. Kim, W.; Kang, K. Recent Developments of Cathepsin Inhibitors and Their Selectivity. Expert Opin. Ther. Patents 2002, 12, 419-432.
8. Bergmann, E. M.; James, M. N. G. The 3C Proteinases of Picornaviruses and other Positive-Sense, Single-Stranded RNA Viruses. In Handbook of Experimental Pharmocology: Proteases as Targets for Therapy; Von der Helm, K.; Korant, B.; Eds.; Springer: Heidelberg, 2000; 140, pp 117-143.
9. Bergmann, E. M.; James, M. N. G. Proteolytic Enzymes of the Virus of the Family Picornaviridae. In Proteinases of Infectious Agents; Dunn, B.; Eds.; Academic Press: San Diego, CA, 1999; pp 139-163.
10. Malcolm, B. A. The Picornaviral 3C Proteinases: Cysteine Nucleophiles in Serine Proteinase Folds. Protein Sci. 1995, 4, 1439-1445.
11. Toyoda, H.; Nicklin, M. J.; Murray, M. G.; Anderson, C. W.; Dunn, J. J.; Studier, F. W.; Wimmer, E. A Second Virus-encoded Proteinase Involved in Proteolytic Processing of Poliovirus Polyprotein. Cell 1986, 45, 761-770.
12. Sommergruber, W.; Zorn, M.; Blaas, D.; Fessi, F.; Volkmann, P.; Maurer-Fogy, I.; Pallai, P.; Merluzzi, V.; Matteo, M.; Skern, T.; Kuechler, E. Polypeptide 2A of Human Rhinovirus Type 2: Identification as a Protease and Characterization by Mutational Analysis. Virology 1989, 169, 68-77.
13. Allaire, M.; Chernaia, M. M.; Malcolm, B. A.; James, M. N. G. Picornaviral 3C Cysteine Proteinases have a Fold Similar to Chymotrypsin-like Serine Proteinases. Nature 1994, 369, 72-76.
14. Jewell, D. A.; Swietnicki, W.; Dunn, B. M.; Malcolm, B. A. Hepatitis A Virus 3C Proteinase Substrate Specificity. Biochemistry 1992, 31, 7862-7869.
15. Bergmann, E. M.; Mosimann, S. C.; Chernaia, M. M.; Malcolm, B. A.; James, M. N. G. The Refined Crystal Structure of the 3C Gene Product from Hepatitis A Virus: Specific Proteinase Activity and RNA Recognition. J. Virol. 1997, 71, 2436-2448.
16. Matthews, D. A.; Smith, W. W.; Ferre, R. A.; Condon, B.; Budahazi, G.; Sisson, W.; Villafranca, J. E.; Janson, C. A.; McElroy, H. E.; Gribskov, C. L. Structure of Human Rhinovirus 3C Protease Reveals a Trypsin-like Polypeptide Fold, RNA-binding Site, and Means for Cleaving Precursor Polyprotein. Cell 1994, 77, 761-771.
17. Schechter, I.; Berger, A. On the Size of the Active Site in Proteases. I. Papain. Biochem. Biophys. Res. Commun. 1967, 27, 157-162.
18. Mehdi, S. Synthetic and Naturally Occurring Protease Inhibitors Containing an Electrophilic Carbonyl Group. Bioorg. Chem. 1993, 21, 249-259.
19. Shaw, E. Cysteinyl Proteinases and their Selective Inactivation. Adv. Enzymol. 1990, 271-346.
20. McKendrick, J. E.; Frormann, S.; Luo, C.; Semchuck, P.; Vederas, J. C.; Malcolm, B. A. Rapid Mass Spectrometric Determination of Preferred Irreversible Proteinase Inhibitors in Combinatorial Libraries. Int. J. Mass Spectrom. 1998, 176, 113-124.
21. Kay, J.; Dunn, B. M. Viral Proteinases: Weakness in Strength. Biochim. Biophys. Acta 1990, 1048, 1-18.
22. Bergmann, E. M.; Cherney, M. M.; McKendrick, J.; Frormann, S.; Luo, C.; Malcolm, B. A.; Vederas, J. C.; James, M. N. G. Crystal Structure of an Inhibitor Complex of the 3C Proteinase from Hepatitis A Virus (HAV) and Implications for the Polyprotein Processing in HAV. Virology 1999, 265, 153-163.
23. Lowe, C.; Vederas, J. C. Naturally Occurring Beta-Lactones: Occurrence, Syntheses and Properties. Org. Prep. Proc. Int. 1995, 27, 305-346.
24. Pommier, A.; Pons, J.-M. The Synthesis of Natural 2-Oxetanones. Synthesis 1995, 7, 729-744.
25. Yang, H. W.; Romo, D. Methods for the Synthesis of Optically Active β-Lactones (2-Oxetanones). Tetrahedron 1999, 55, 6403-6434.
26. α-(Benzyloxycarbonyl)-β-(pyrazol-1-yl)-L-alanine. Org. Syn. 1991, 70, 1-9.
27. Pansare, S. V.; Arnold, L. D.; Vederas, J. C. Synthesis of N-tert-Butoxycarbonyl-L-serine β-Lactone and the p-Toluenesulfonic Acid Salt of (S)-3-Amino-2-oxetanone. Org. Syn. 1991, 70, 10-17.
28. Arnold, L. D.; Kalantar, T. H.; Vederas, J. C. Conversion of Serine to Stereochemically Pure β-Substituted α-Amino Acids via β-Lactones. J. Am. Chem. Soc. 1985, 107, 7105-7109.
29. Arnold, L. D.; May, R. G.; Vederas, J. C. Synthesis of Optically Pure α-Amino Acids via Salts of α-Amino-β -Propiolactone. J. Am. Chem. Soc. 1988, 110, 2237-2241.
30. N2 Ring Opening of β-Lactones: An Alternative to Catalytic Asymmetric Conjugate Additions. J. Org. Chem. 2002, 67, 4680-4683.
31. Etienne, Y.; Fischer, N. β-Lactones. In The Chemistry of Heterocyclic Compounds; Weissberger, A.; Eds.; Interscience: New York, 1964; 19(Pt. 2), pp 729-884.
32. Ramer, S. E.; Moore, R. N.; Vederas, J. C. Mechanism of Formation of Serine β-Lactones by Mitsunobu Cyclization: Synthesis and Use of L-Serine Stereospecifically Labelled with Deuterium at C-3. Can. J. Chem. 1986, 64, 706-713.
33. Lall, M. S.; Karvellas, C.; Vederas, J. C. β-Lactones as a New Class of Cysteine Proteinase Inhibitors: Inhibition of Hepatitis A Virus 3C Proteinase by N-Cbz-Serine β-Lactone. Org. Lett. 1999, 1, 803-806.
34. Lall, M. S.; Ramtohul, Y. K.; James, M. N. G.; Vederas, J. C. Serine and Threonine β-Lactones: A New Class of Hepatitis A Virus 3C Cysteine Proteinase Inhibitors. J. Org. Chem. 2002, 67, 1536-1547.
35. Aldridge, D. C.; Nicholson, S.; Taylor, P. J. Rates and Mechanisms for the Ring Opening, Ring Closure and Ring Transformation Reactions of the Di-γ-lactone Dihydrocanadensolide (DHC). J. Chem. Soc., Perkin Trans. 2 1995, 1929-1938.
36. Huisgen, R.; Ott, H. Die Konfiguration Der Carbonestergruppe Und Die Sondereigenschaften Der Lactone. Tetrahedron 1959, 6, 253-267.
37. Jhoti, H.; Cleasby, A.; Reid, S.; Thomas, P. J.; Weir, M.; Wonacott, A. Crystal Structures of Thrombin Complexed to a Novel Series of Synthetic Inhibitors Containing a 5,5-trans-Lactone Template. Biochemistry 1999, 38, 7969-7977.
38. Kelly, H. A.; Bolton, R.; Brown, S. A.; Coote, S. J.; Dowle, M.; Dyer, U.; Finch, H.; Golding, D.; Lowdon, A.; McLaren, J.; Montana, J. G.; Owen, M. R.; Pegg, N. A.; Ross, B. C.; Thomas, R.; Walker, D. A. Synthesis of Trans-Fused [5,5] Bicyclic Lactones/Lactams as Templates for Serine Protease Inhibition. Tetrahedron Lett. 1998, 39, 6979-6982.
39. Mitchell, A. E.; Zheng, J.; Hammock, B. D.; Lo Bello, M.; Jones, A. D. Structural and Functional Consequences of Haloenol Lactone Inactivation of Murine and Human Glutathione S-Transferase. Biochemistry 1998, 37, 6752-6759.
40. Vaughan, W. R.; Baumann, J. B. Reactions of Alkyl Carboxylic Esters with Mercaptides. J. Org. Chem. 1962, 27, 739-741.
41. Schwab, J. M.; Ray, T.; C.-K. Ho, C.-K. Synthesis of (2R,3R)- and (2S,3S)-[2,3-2H2]oxirane and Application of It to the Synthesis of Chirally Labeled Homoserine. J. Am. Chem. Soc. 1989, 111, 1057-1063.
42. Yoakim, C.; Ogilivie, W. W.; Cameron, D. R.; Chabot, C.; Guse, I. Haché, B.; Naud, J.; O'Meara, J. A.; Plante, R.; Déziel, R. β-Lactam Derivatives as Inhibitors of Human Cytomegalovirus Protease. J. Med. Chem. 1998, 41, 2882-2891.
43. 0 With Monocyclic β-Lactams. Bioorg Med. Chem. Lett. 1998, 8, 1437-1442.
44. Hanessian, S.; Sahoo, S. P.; Couture, C.; Wyss, H. Novel Synthetic Approaches to Monocyclic β-Lactam Antibiotics. Bull. Soc. Chim. Belg. 1984, 93, 571-578.
45. Dollinger, L. M.; Howell, A. R. A 2-Methyleneoxetane Analog of Orlistat Demonstrating Inhibition of Porcine Pancreatic Lipase. Bioorg Med. Chem. Lett. 1998, 8, 977-978.
46. Dollinger, L. M.; Ndakala, A. J.; Hashemzadeh, M.; Wang, G.; Wang, Y.; Martinez, I.; Arcari, J. T.; Galluzzo, D. J.; Howell, A. R. Preparation and Properties of 2-Methyleneoxetane. J. Org. Chem. 1999, 64, 7074-7080.
47. Bisel, P.; Breitling, E.; Frahm, A. W. Diastereo- and Enantioselective Synthesis of (+)- and (-)-cis-2-Aminocyclobutanols. Eur. J. Org. Chem. 1998, 729-733.
48. Morris, T. S.; Frormann, S.; Shechosky, S.; Lowe, C.; Lall, M. S.; Gauss-Müller, V.; Purcell, R. H.; Emerson, S. U.; Vederas, J. C.; Malcolm, B. A. In Vitro and Ex Vivo Inhibition of Hepatitis A Virus 3C Proteinase by a Peptidyl Monofluoromethyl Ketone. Bioorg. Med. Chem. 1997, 5, 797-807.
49. Sengupta, S.; Das, D. First Example of Intramolecular C-H Insertion Reaction in an Amino Acid Derived α-Diazoketone. Syn. Commun. 1998, 3, 403-408.
50. Ye, T.; McKervey, M. A. Organic Synthesis with α-Diazo Carbonyl Compounds. Chem. Rev. 1994, 94, 1091-1160.
51. 2: An Efficient Route to Derivatives of 3-Oxoazetidines, 3-Oxopyrrolidines and 3-Oxopiperidines. J. Chem. Soc., Perkin Trans. 1 1999, 2277-2280.
52. Kim, D. H.; Ryoo, J. J. (3R,4S)-3-Benzyl-4-bromomethyloxetan-2-one, A Fast Acting Alternate Substrate Inhibitor of α-Chymotrypsin. Bioorg. Med. Chem. Lett. 1995, 5, 1287-1292.
53. Corey, E. J.; Li, W.; Nagamitsu, T. An Efficient and Concise Enantioselective Total Synthesis of Lactacystin. Angew. Chem. Int. Ed. Engl. 1998, 37, 1676-1679.
54. Romo, D.; Harrison, P. H. M.; Jenkins, S. I.; Riddoch, R. W.; Park, K.; Yang, H. W.; Zhao, C.; Wright, G. D. Synthesis and Inhibitory Action On HMG-CoA Synthase of Racemic and Optically Active Oxetan-2-ones (β-Lactones). Bioorg. Med. Chem. 1998, 6, 1255-1272.
55. Mayer, R. J.; Louis-Flamberg, P.; Elliott, J. D.; Fisher, M.; Leber, J. Inhibition of 3-Hydroxy-3-methylglutaryl CoEnzyme A Synthase by Antibiotic 1233A and Other β-Lactones. Biochem. Biophys. Res. Commun. 1990, 169, 610-616.
56. Lüthi-Peng, Q.; Märki, H. P.; Hadváry, P. Identification of the Active-site Serine in Human Pancreatic Lipase by Chemical Modification with Tetrahydrolipstatin. FEBS Lett. 1992, 299, 111-115.
57. Hadváry, P.; Sidler, W.; Meister, W.; Vetter, W.; Wolfer, H. The Lipase Inhibitor Tetrahydrolipstatin Binds Covalently to the Putative Active Site Serine of Pancreatic Lipase. J. Biol. Chem. 1991, 266, 2021-2027.
58. Kocienski, P. J.; Pelotier, B.; Pons, J.-M.; Prideaux, H. Asymmetric Syntheses of Panclicins A-E via [2+2] Cycloaddition of alkyl(trimethylsilyl)ketenes to a β-Silyloxyaldehyde. J. Chem. Soc., Perkin Trans. 1 1998, 1373-1382.
59. Pearson, R. G. Hard and Soft Acids and Bases-The Evolution of a Chemical Concept. Coord. Chem. Rev. 1990, 100, 403-425.
60. Hanzlik, R. P.; Thompson, S. A. Vinylogous Amino Acid Esters: A New Class of Inactivators For Thiol Proteases. J. Med. Chem. 1984, 27, 711-712.
61. Ramtohul, Y. K. Doctoral thesis, University of Alberta, 2002.
62. Dragovich, P. S.; Prins, T. J.; Zhou, R.; Brown, E. L.; Maldonado, F. C.; Fuhrman, S. A.; Zalman, L. S.; Tuntland, T.; Lee, C. A.; Patick, A. K.; Matthews, D. A.; Hendrickson, T. F.; Kosa, M. B.; Liu, B.; Batugo, M. R.; Gleeson, J.-P. R.; Sakata, S. K.; Chen, L.; Guzman, M. C.; Meador III, J. W.; Ferre, R. A.; Worland, S. T. Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure-Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics. J. Med. Chem. 2002, 45, 1607-1623.
63. Hill, R. D.; Vederas, J. C. Azodicarboxamides: A New Class of Cysteine Proteinase Inhibitor for Hepatitis A Virus and Human Rhinovirus 3C Enzymes. J. Org. Chem. 1999, 64, 9538-9546.
64. Gante, J. Azapeptides. Synthesis 1989, 405-413.
65. Han, H.; Janda, K. D. Azatides: Solution and Liquid Phase Syntheses of a New Peptidomimetic. J. Am. Chem. Soc. 1996, 118, 2539-2544.
66. Sham, H. L.; Rosenbrook, W.; Kati, W.; Betebenner, D. A.; Wideburg, N. E.; Saldivar, A.; Plattner, J. J.; Norbeck, D. W. Potent Inhibitor of the Human Rhinovirus (HRV) 3C Protease Containing a Backbone Modified Glutamine. J. Chem. Soc., Perkin Trans. 1 1995, 1081-1082.
67. Babine, R. E.; Bender, S. L. Molecular Recognition of Protein-Ligand Complexes: Applications to Drug Design. Chem. Rev. 1997, 97, 1359-1472.
68. Yamashita, D. S.; Smith, W. W.; Zhao, B.; Janson, C. A.; Tomaszek, T. A.; Bossard, M. J.; Levy, M. A.; Oh, H.-J.; Carr, T. J.; Thompson, S. K.; Ijames, C. F.; Carr, S. A.; McQueney, M.; D'Alessio, K. J.; Amegadzie, B. Y.; Hanning, C. R.; Abdel-Meguid, S.; DesJarlais, R. L.; Gleason, J. G.; Veber, D. F. Structure and Design of Potent and Selective Cathepsin K Inhibitors. J. Am. Chem. Soc. 1997, 119, 11351-11352.
69. Marquis, R. W.; Yamashita, D. S.; Ru, Y.; LoCastro, S. M.; Oh, H.-J.; Erhard, K. F.; DesJarlais, R. L.; Head, M. S.; Smith, W. W.; Zhao, B.; Janson, C. A.; Abdel-Meguid, S. S.; Tomaszek, T. A.; Levy, M. A.; Veber, D. F. Conformationally Constrained 1,3-Diamino Ketones: A Series of Potent Inhibitors of the Cysteine Protease Cathepsin K. J. Med. Chem. 1998, 41, 3563-3567.
70. Marquis, R. W.; Ru, Y.; Yamashita, D. S.; Oh, H.-J.; Yen, J.; Thompson, S. K.; Carr, T. J.; Levy, M. A.; Tomaszek, T. A.; Ijames, C. F.; Smith, W. W.; Zhao, B.; Janson, C. A.; Abdel-Meguid, S. S.; D'Alessio, K. J.; McQueney, M. S.; Veber, D. F. Potent Dipeptidylketone Inhibitors of the Cysteine Protease Cathepsin K. Bioorg. Med. Chem. 1999, 7, 581-588.
71. Ding, J.; Fraser, M. E.; Meyer, J. H.; Bartlett, P. A.; James, M. N. G. Macrocyclic Inhibitors of Penicillopepsin. 2. X-ray Crystallographic Analyses of Penicillopepsin Complexed with a P3-P1 Macrocyclic Peptidyl Inhibitor and with Its Two Acyclic Analogues. J. Am. Chem. Soc. 1998, 120, 4610-4621.
72. Meyer, J. H.; Bartlett, P. A. Macrocyclic Inhibitors of Penicillopepsin. 1. Design, Synthesis and Evaluation of an Inhibitor Bridged between P1 and P3, J. Am. Chem. Soc. 1998, 120, 4600-4609.
73. Smith, W. W.; Bartlett, P. A. Macrocyclic Inhibitors of Penicillopepsin. 3. Design, Synthesis and Evaluation of an Inhibitor Bridged between P2 and P1′. J. Am. Chem. Soc. 1998, 120, 4622-4628.
74. Khan, A. R.; Parrish, J. C.; Fraser, M. E.; Smith, W. W.; Bartlett, P. A.; James, M. N. G. Lowering the Entropic Barrier for Binding Conformationally Flexible Inhibitors to Enzymes. Biochemistry 1998, 37, 16839-16845.
75. Kim, B. H.; Soo, G. C.; Ha, T.-K. An ab Initio Study of Intramolecular Hydrogen Bondings in α-Hydroxy Ketomethylene Dipeptide Isostere. J. Org. Chem. 1999, 64, 5036-5041.
76. Chung, Y. J.; Ryu, E. J.; Keum, G.; Kim, B. H. Synthesis of 2-Isoxazoline and α-Hydroxy Ketomethylene Dipeptide Isosteres. Bioorg. Med. Chem. 1996, 4, 209-225.
77. Kim, B, H.; Chung, Y. J.; Ryu, E. J. Synthesis of α-Hydroxy Ketomethylene Dipeptide Isosteres. Tetrahedron Lett. 1993, 34, 8465-8468.
78. Ramtohul, Y. K.; James, M. N. G.; Vederas, J. C. Synthesis and Evaluation of Keto-Glutamine Analogues as Inhibitors of Hepatitis A Virus 3C Proteinase. J. Org. Chem. 2002, 67, 3169-3178.
79. Malcolm, B. A.; Lowe, C.; Shechosky, S.; McKay, R. T.; Yang, C. C.; Shah, V. J.; Simon, R. J.; Vederas, J. C.; Santi, D. V. Peptide Aldehyde Inhibitors of Hepatitis A Virus 3C Proteinase. Biochemistry 1995, 34, 8172-8179.
80. Liskamp, R. M. J. Conformationally Restricted Amino Acids and Dipeptides, (Non)Peptidomimetics and Secondary Structure Mimetics. Recl. Trav. Chim. Pays-Bas 1994, 113, 1-19.
81. Scheidt, K. A.; Roush, W. R.; McKerrow, J. H.; Selzer, P. M.; Hansell, E.; Rosenthal, P. J. Structure-Based Design, Synthesis and Evaluation of Conformationally Constrained Cysteine Protease Inhibitors. Bioorg. Med. Chem. 1998, 6, 2477-2494.
82. Dumez, E.; Snaith, J. S.; Jackson, R. F. W.; McElroy, A. B.; Overington, J.; Wythes, M. J.; Withka, J. M.; McLellan, T. J. Synthesis of Macrocyclic, Potential Protease Inhibitors Using a Generic Scaffold. J. Org. Chem. 2002, 67, 4882-4892.
83. Brady, S. F.; Paleveda, J. W. J.; Arison, B. H.; Saperstein, R.; Brady, E. J.; Raynor, K.; Reisine, T.; Veber, D. F.; Freidinger, R. M. Approaches to Peptidomimetrics which serve as Surrogates for the cis Amide Bond: Novel Disulfide-Constrained Bicyclic Hexapeptide Analogs of Somatostatin. Tetrahedron 1993, 49, 3449-3466.
84. Osapay, G.; Taylor, J. W. Multicyclic Polypeptide Model Compounds. 1. Synthesis of a Tricyclic Amphiphilic α-Helical Peptide Using An Oxime Resin, Segment-Condensation Approach. J. Am. Chem. Soc. 1990, 112, 6046-6051.
85. Blackwell, H. E.; Grubbs, R. H. Highly Efficient Synthesis of Covalently Cross-Linked Peptide Helices by Ring-Closing Metathesis. Angew. Chem. Int. Ed. 1998, 37, 3281-3284.
86. Miller, S. J.; Blackwell, H. E.; Grubbs, R. H. Application of Ring-Closing Metathesis to the Synthesis of Rigidified Amino Acids and Peptides. J. Am. Chem. Soc. 1996, 118, 9606-9614.
87. Miller, S. J.; Grubbs, R. H. Synthesis of Conformationally Restricted Amino Acids and Peptides Employing Olefin Metathesis. J. Am. Chem. Soc. 1995, 117, 5855-5856.
88. Reichwein, J. F.; Cornelis, V.; Liskamp, R. M. J. Synthesis of Cyclic Peptides by Ring-Closing Metathesis. J. Org. Chem. 2000, 65, 6187-6195.
89. Cornforth, W. J. Oxazole and Its Derivatives. In Heterocyclic Compounds: Five-Membered Heterocycles Containing Two Hetero Atoms and Their Derivatives; Elderfield, R. C.; Ed.; Wiley: New York, 1957, 5, pp 336-377.
90. Filler, R. Recent Advances in Oxazolone Chemistry. In Advances in Heterocyclic Chemistry; Katritzky, A. R.; Ed.; Academic Press: New York, 1965; 4, pp 75-106.
91. Kaneda, A.; Sudo, R. Preparation of α-Amino-α-benzylthiopropionic Acid Derivatives. Bull. Chem. Soc. Jpn. 1970, 43, 2159-2161.
92. Knunyants, I. L.; Kil'disheva, O. V.; Krasuskaya, M. P.; Lin'kova, M. G.; Shokina, V. V.; Benevolenskaya, Z. V.; Rasteikene, L. P. Transformations of Mercapto Amino Acids. XII. Acylation of Dimethylcysteine with α-Acylaminoacrylic Acids and Pseudoxazolones. Izvest. Akad. Nauk. U.S.S.R. Otdel. Khim. Nauk. 1959, 1777-1786.
93. Ramtohul, Y. K.; Martin, N. I.; Silkin, L.; James, M. N. G.; Vederas, J. C. Synthesis of Pseudoxazolones and their Inhibition of the 3C Cysteine Proteinases from Hepatitis A Virus and Human Rhinovirus-14. J. Chem. Soc. Perkin Trans. 1 2002, 1351-1359.